Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of GSK2798745 formulations in healthy subjects
NCT02925546Phase 1Completed
- Sponsor
- GSK
- Start
- Oct 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of GSK2798745 in pulmonary edema and heart failure (HF) (6 arms), sponsored by GSK. Primary endpoints: Area under the curve of GSK2798745 and Maximum plasma concentration of GSK2798745. Started Oct 2016; status: completed.
02
Drugs
GSK2798745
03
Conditions
pulmonary edemaheart failure (HF)
Beyond the preview
Go deeper on NCT02925546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02925546.